Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News GSK and MRC form genetic biomarker partnership

GSK and MRC form genetic biomarker partnership

31st January 2008

GlaxoSmithKline (GSK) and the Medical Research Council (MRC) have announced the launch of a jointly funded programme that aims to identify new therapeutic targets and biomarkers from genetic association studies.

The partnership is designed to validate genes linked to common human diseases, translating observations into new targets and biomarkers of disease.

Over the next three years, GSK and MRC will invest one million pounds into the programme which aims to bring together academic and industrial expertise and resources.

Projects funded by the programme will also benefit from shared databases and sample collections when studying the role of genes in common human diseases.

Dr Patrick Vallance, senior vice-president of drug discovery at GSK, welcomed the collaboration and predicted an “exciting working partnership” with MRC.

“We have worked hard to collect and refine our data but we now need to take a bold step forwards and work with others to uncover the new disease targets and genetic variations that are useful to inform drug discovery and development,” he outlined.

The MRC’s chief executive Sir Leszek Borysiewicz added that the project highlighted the collaborative working relationships that now thrive between public and private research in the UK.

Earlier this week, GSK announced the appointment of Lon Cardon as head of the company’s genetics organisation.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.